DSC Advisors, L.P. - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445107. A total of 31 filers reported holding KEMPHARM INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DSC Advisors, L.P. ownership history of KEMPHARM INC
ValueSharesWeighting
Q1 2020$922,000
-40.7%
4,095,9140.0%0.90%
+20.8%
Q4 2019$1,554,000
-44.9%
4,095,9140.0%0.74%
+33.5%
Q3 2019$2,821,000
-60.6%
4,095,9140.0%0.56%
-55.7%
Q2 2019$7,168,000
+4.8%
4,095,9140.0%1.26%
+0.2%
Q1 2019$6,840,000
-6.2%
4,095,9140.0%1.26%
+42.5%
Q4 2018$7,291,000
-27.5%
4,095,914
+95.4%
0.88%
-34.6%
Q3 2018$10,060,000
-13.6%
2,095,914
+17.0%
1.35%
-28.8%
Q2 2018$11,646,000
-17.7%
1,791,6310.0%1.90%
-36.0%
Q1 2018$14,154,000
+95.1%
1,791,6310.0%2.96%
-29.7%
Q4 2017$7,256,000
+9.5%
1,791,6310.0%4.21%
+99.3%
Q3 2017$6,629,000
+13.6%
1,791,631
+22.8%
2.11%
+9.8%
Q2 2017$5,837,000
-18.4%
1,459,1930.0%1.92%
-60.5%
Q1 2017$7,150,000
+66.1%
1,459,1930.0%4.87%
+99.6%
Q4 2016$4,305,000
+1.6%
1,459,193
+54.7%
2.44%
-5.2%
Q3 2016$4,236,000
+12.8%
943,4850.0%2.57%
+8.9%
Q2 2016$3,755,000
-71.0%
943,485
+5.6%
2.36%
-69.3%
Q1 2016$12,957,000
-18.6%
893,558
+11.5%
7.70%
-7.4%
Q4 2015$15,913,000
+31.4%
801,257
+28.2%
8.31%
+41.4%
Q3 2015$12,111,000
+21.0%
624,900
+14.7%
5.88%
+12.9%
Q2 2015$10,005,000544,6435.20%
Other shareholders
KEMPHARM INC shareholders Q4 2017
NameSharesValueWeighting ↓
Arete Wealth Advisors, LLC 987,111$19,604,00011.88%
DSC Advisors, L.P. 801,257$15,913,0008.31%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,420,497$28,211,0001.14%
Boyle Capital Management, L.L.C. 34,094$677,0000.93%
Broadfin Capital, LLC 732,338$14,544,0000.90%
Endurant Capital Management LP 104,886$2,083,0000.70%
SPHERA FUNDS MANAGEMENT LTD. 183,954$3,653,0000.54%
Iowa State Bank 19,020$378,0000.22%
KINGDON CAPITAL MANAGEMENT, L.L.C. 203,390$4,039,0000.20%
DRIEHAUS CAPITAL MANAGEMENT LLC 251,689$4,999,0000.17%
View complete list of KEMPHARM INC shareholders